Cancer Stem Cells in Pancreatic Cancer
Qi Bao, Yue Zhao, Andrea Renner, Hanno Nieß, Hendrik Seeliger, Karl‐Walter Jauch, Christiane J. Bruns
Abstract
Open-access reader
Qi Bao, Yue Zhao, Andrea Renner, Hanno Nieß, Hendrik Seeliger, Karl‐Walter Jauch, Christiane J. Bruns
Abstract
Open-access reader
Pancreatic cancer is an aggressive malignant solid tumor well-known by early metastasis, local invasion, resistance to standard chemo- and radiotherapy and poor prognosis. Increasing evidence indicates that pancreatic cancer is initiated and propagated by cancer stem cells (CSCs). Here we review the current research results regarding CSCs in pancreatic cancer and discuss the different markers identifying pancreatic CSCs. This review will focus on metastasis, microRNA regulation and anti-CSC therapy in pancreatic cancer.
OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Pancreatic cancer is an aggressive malignant solid tumor well-known by early metastasis, local invasion, resistance to standard chemo- and radiotherapy and poor prognosis. Increasing evidence indicates that pancreatic cancer is initiated and propagated by cancer stem cells (CSCs). Here we review the current research results regarding CSCs in pancreatic cancer and discuss the different markers identifying pancreatic CSCs. This review will focus on metastasis, microRNA regulation and anti-CSC therapy in pancreatic cancer.
Key concepts: Pancreatic cancer, Cancer stem cell, Cancer, Metastasis, Medicine, Cancer research, Radiation therapy, Oncology